Neurochemical Markers of Degenerative Nervous Diseases and Drug Addiction

Couverture
G. a. Qureshi
VSP, 1998 - 857 pages
 

Table des matières

Preface
1
Vitamin B₁ concentration as a marker of dementia
12
Monitoring of excitotoxicity in neurologic disorders
57
An early and central event in the pathogenesis
93
Pathological
111
Prospects of recombinasemediated HPRT gene therapy
133
Opioid peptides in drug dependence and neurological diseases
171
Alcoholic intoxication
193
Polyamines and related compounds as markers of physiopathology
461
Monoamine oxidase neurotoxicity and methodology
495
Dynorphin converting enzymes and strategies
523
Apoliprotein E in Alzheimers disease dementia with Lewybodies
547
Classical neurotransmitters and their correlation with neuropeptides
569
Cerebrospinal fluid markers of HIV1 infection
597
Brain lipid levels in neurodegenerative disorders
619
Novel fluorometry of norsalsolinol an endogenous
649

Roles for dopamine glutamate
223
Identification of emesis induced by centrally acting drugs
245
Minami S I Kimura K I Ueno T Endo M Hirafuji
265
Histamine
285
Abnormal tryptophan metabolism neurologicpsychiatric
351
Acetylcholine catecholamine indolamine and GABA levels
383
Analysis of salsolinols endogenous neurotoxins
413
Biopterin and neopterin as neurochemical markers
673
Neuropeptide analysis in human pituitary tumors
723
Studies on neuronal apoptosis using a COMET assay
781
Three dimensional HPLCEC analyses of regional brain
817
HPLC as a tool in quantitation of CSF biopterin neopterin
839
List of Contributors
853
Droits d'auteur

Expressions et termes fréquents

Informations bibliographiques